A clinical decision guide for women in perimenopause who are weighing whether to start HRT. Covers the symptoms that signal readiness, what the research says about timing, who benefits most, what's changed since the WHI study, and how to walk into a provider appointment prepared, including what hormone data to bring.

A clinical decision guide for women in perimenopause who are weighing whether to start HRT. Covers the symptoms that signal readiness, what the research says about timing, who benefits most, what's changed since the WHI study, and how to walk into a provider appointment prepared, including what hormone data to bring.
You've been dealing with it for months, maybe years. The sleep that never feels restorative. The heat that wakes you at 3am. The mood that isn't yours. The brain that stalls mid-sentence. You've been told you're "too young," that your labs look fine, that you should try yoga or antidepressants or just wait it out.
And now you're asking the question that brings most women to this page: Is it time to start HRT?
This guide won't make that decision for you, that belongs to you and your provider. But it will give you what you actually need to make it: a clear picture of what the research says, the specific signals that suggest it's time, what's changed about HRT safety in the past few years, and how to walk into your next appointment prepared.
First: Why This Decision Feels So Hard
The confusion around HRT is not your fault. For more than two decades, a deeply flawed interpretation of the Women's Health Initiative (WHI) study caused providers to withhold or delay HRT from women who would have clearly benefited from it. The study's headline findings, linking HRT to increased breast cancer and cardiovascular risk, were applied to the wrong population. The WHI studied older women, most of whom were 60+ years old, postmenopausal, many of whom were already at elevated cardiovascular risk, using an oral estrogen and synthetic oral progestin. The WHI excluded perimenopausal women entirely, the very population for whom symptom-driven HRT initiation is increasingly supported by current evidence.
In November 2025, the FDA removed the black box warning that had sat on HRT labeling for 22 years, a formal acknowledgment that the evidence had shifted. As Oova's own coverage of that moment noted, the science behind HRT has been rewritten, and starting treatment during perimenopause, rather than waiting, is now understood to be the point of maximum benefit.
That context matters, because many women asking "is it time?" are actually asking "is it safe?" The answer, for most healthy women in perimenopause, is likely yes.
What HRT Actually Does
Hormone replacement therapy, typically transdermal estradiol plus progesterone for women with a uterus, restores hormonal levels that the ovaries are no longer producing reliably. In perimenopause, estrogen and progesterone don't decline in a smooth, predictable curve. They fluctuate widely, with sharp drops and surges that can shift dramatically within a single cycle. HRT doesn't flatten that variability completely, but it establishes a floor, a baseline that prevents the body from dropping into the low-estrogen states that drive the most disruptive symptoms.
Beyond symptom relief, earlier initiation of HRT is associated with meaningful long-term benefits, including preserved bone density and a more favorable cardiovascular and metabolic profile. The "timing hypothesis," the principle that HRT carries a more favorable risk-benefit profile when initiated within 10 years of menopause onset or before age 60, rather than years later, is now supported by substantial evidence. Waiting is not a neutral decision.
7 Signs It May Be Time to Consider HRT
No single symptom is a threshold, and not every woman in perimenopause needs HRT. But when several of these are showing up together, affecting your daily life, and not improving with lifestyle changes alone, it's time for a real conversation with your provider.
1. Sleep disruption you can't explain otherwise
Night sweats are the obvious culprit, but plenty of women describe waking at 2 or 3 a.m. without sweating, just wide awake, wired, and unable to fall back asleep. When the cause is related to perimenopause, it's because shifting estrogen levels disrupt body temperature regulation and the deeper stages of sleep. If sleep apnea, thyroid dysfunction, stress, and caffeine have been ruled out, and the pattern tracks with your cycle or started in your early 40s, perimenopausal hormone changes are a strong candidate.
2. Hot flashes that interrupt your life
Hot flashes and night sweats, known clinically as vasomotor symptoms, are among the most well-studied reasons to start HRT, with the strongest evidence behind them. If yours are frequent, intense, or disruptive enough to affect work, sleep, or social life, that meets the bar for treatment.
3. Mood changes that don't respond to what used to work
Mood symptoms in perimenopause are often complex and multifactorial, and antidepressants remain a valid option for many women. But if you've been offered one without any conversation about the hormonal piece, that may only be part of the solution. For many women, adding hormone therapy improves mood symptoms enough that an antidepressant is no longer needed, or works better in combination. Nearly 40% of perimenopausal women are misdiagnosed, most often with depression, when hormones are part of the story.
4. Brain fog that has changed how you perform
Brain fog in perimenopause isn't the occasional forgotten word or distracted moment. It's words that don't come. Tasks that take twice as long. The sense that your cognitive baseline has shifted. Estrogen supports blood flow to the brain and how brain cells function, and its decline in perimenopause is tied to the cognitive symptoms women describe. While research on HRT and long-term cognition is still evolving, many women report meaningful improvement in day-to-day mental clarity once hormone therapy is in place. These symptoms are worth raising with your provider, not dismissing.
5. Vaginal and urinary symptoms
Vaginal dryness, pain with sex, urinary urgency, and recurrent UTIs are common as estrogen drops, and they tend to get worse with menopause and the further past it you are. Unlike hot flashes, which often improve over time, these symptoms typically don't resolve on their own. The good news: local vaginal estrogen is extremely effective at improving them, and it can be used safely on its own or alongside systemic HRT.
6. Symptoms that have persisted for more than six months
A single rough month can come from any number of things, stress, illness, a difficult cycle. But six months of disrupted sleep, mood instability, and hot flashes can reveal a pattern, and patterns in perimenopause usually point to real hormonal change. If your symptoms have lasted this long and aren't improving on their own, it's time to talk to your provider about treatment.
7. You've done the lifestyle work and it's not enough
Strength training, reduced alcohol, better sleep, stress management, these matter, and they're worth doing whether or not you start HRT. But if you've built a strong foundation and your symptoms are still significant, lifestyle alone may not be enough to fully resolve what you're experiencing. Hormone therapy works alongside that foundation and can meaningfully improve symptoms on top of it.
Not sure which symptoms are hormonal? Oova tracks your estrogen, progesterone, and LH daily, so you can see exactly which hormones line up with your worst days, and bring that data to your next appointment. Start Tracking My Hormones →
What the Research Says About Timing
The current evidence is consistent on one point: starting HRT earlier in the menopause transition is associated with the most favorable risk-benefit profile. Initiation during perimenopause, before the final menstrual period, or within ten years of menopause onset is supported by current Menopause Society and ACOG guidance for symptomatic women without contraindications. Initiating HRT more than ten years after menopause has not shown the same cardiovascular benefit and may carry higher risk.
This is why earlier, symptom-driven conversations matter. The guidance around hormone therapy has evolved significantly in recent years, and if your symptoms are affecting your quality of life, it's appropriate to raise HRT as an option with your provider, you don't have to wait for symptoms to worsen before having that conversation.
It's also worth knowing: there is no clinical requirement to confirm menopause before starting HRT. Both the Menopause Society's 2022 Hormone Therapy Position Statement and ACOG support hormone therapy as appropriate treatment for bothersome perimenopausal symptoms in women without contraindications. You do not need to have stopped having periods to be a candidate.
Who HRT Is Not Right For
HRT is not appropriate for everyone, and this guide cannot replace individualized clinical assessment. HRT is generally contraindicated or requires careful risk-benefit evaluation for women with:
- A personal history of hormone receptor-positive breast cancer
- A history of blood clots (DVT or PE), particularly without a reversible cause
- Unexplained vaginal bleeding
- Active liver disease
- Certain cardiovascular conditions (discuss with your provider)
If any of these apply to you, the conversation with your provider is still worth having. A dedicated risk-benefit discussion can help you understand your options and the rationale for each, including non-hormonal therapies, low-dose vaginal estrogen, and other individualized approaches.
What Standard Hormone Labs Don't Capture
Many women hear that their hormone labs came back normal and conclude they're not in perimenopause, or that hormone therapy isn't warranted. But normal labs on a single blood draw don't tell the whole story.
A one-time “normal” FSH or estradiol level is an accurate interpretation of that specific moment. The limitation isn't the test itself; it's that a single moment can't reflect what's happening hormonally across an entire cycle, especially during perimenopause when variability is the defining feature. Estradiol can range anywhere from under 50 pg/mL during menstruation to over 300 pg/mL near ovulation in a single normal cycle, and in perimenopause, that range becomes even less predictable from one cycle to the next.
So a woman whose estradiol fluctuates significantly within a cycle might have her blood drawn on a day when her level reads 150, well within the normal range, even though her overall pattern reflects clear perimenopausal change. The lab result is correct. It's just incomplete.
This is the gap in standard testing for perimenopause: snapshot bloodwork captures a single point in time, not the cycle-level pattern of fluctuation that actually drives symptoms. A woman whose estradiol drops sharply from 200 to 40 in a week feels that drop.
If your labs have come back normal but your symptoms are clearly disrupting your life, the issue is with the limits of standard testing for this stage, which can't reflect what's happening across your entire cycle or from one cycle to the next. Daily at-home tracking, like Oova, was designed for exactly this gap: capturing the cycle-level hormonal pattern that conventional bloodwork can't.
What to Bring to Your Appointment
Documenting your symptoms over time, ideally alongside your hormone pattern, can make your appointment significantly more productive. It moves the conversation from a verbal description of how you've been feeling to a documented pattern your provider can work with.
Tracking that's especially useful:
- How your estradiol and progesterone move across your cycle
- The days your symptoms are worst, and what your hormone levels look like on those days
- Whether your LH is elevated or erratic, which can support a perimenopause staging conversation
- How long your symptoms have been present, along with their frequency and severity
When your provider can see that your estradiol drops significantly in the late luteal phase and that's reliably when you have your worst sleep, the conversation shifts. You're no longer describing a vague experience, you're presenting a hormonal pattern, and that creates a clearer path to a treatment plan.
What Happens After You Start
If you and your provider decide to begin HRT, knowing what to expect helps. The relief is not instant, and may take longer than many women anticipate.
Different symptoms respond at different rates. Hot flashes often begin to improve within two to four weeks. Sleep can take four to eight weeks to meaningfully stabilize. Mood, cognition, and vaginal symptoms may take longer still. Optimal symptom improvement on a new dose or new regimen often takes eight to twelve weeks. Our week-by-week guide to what happens after starting HRT walks through what to expect at each stage.
Finding the right dose often takes more than one adjustment. Many women need at least one change in the first three to six months, and that's a normal part of dialing in your regimen, not a sign that HRT isn't working for you. Knowing the signs that your dose may need recalibration, persistent symptoms, new side effects, or symptoms that improved and then returned, lets you flag them early. If symptoms improved and then came back, that's worth a conversation with your provider to understand what's shifted: why HRT stops working covers the most common reasons.
Understanding how your delivery method affects absorption, and the differences between patches, gels, creams, and oral options, also matters for getting to the right regimen efficiently.
For more on what hormone levels can look like once you're on treatment and what a realistic stabilization timeline looks like, our first 90 days of HRT guide walks through it in detail.
Already started HRT but not sure it's working? Track your daily estradiol and progesterone with Oova to see how your levels are responding, and bring real data to your next dose conversation. Get the Oova Perimenopause Kit →
The Decision, Summarized
HRT is not the right answer for everyone. But for many healthy women in perimenopause whose symptoms are interfering with their quality of life, current evidence supports earlier initiation, and the long-standing concerns rooted in the original WHI interpretation have been meaningfully recontextualized by more recent research. For the right candidate, the potential benefits, both for symptom relief and long-term health, are significant.
If you've been waiting for your symptoms to get bad enough or waiting for labs to confirm what you already know, you have more options than you may realize.
Not sure where you are in the transition? Oova tracks your hormones daily, with lab-grade accuracy, no needles, and results in under 10 minutes. FSA/HSA eligible. Start Tracking →
About the author

Sources
- Manson JE, et al. "Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality." JAMA. 2017;318(10):927–938.
- Harlow SD, et al. "Executive Summary of the Stages of Reproductive Aging Workshop +10 (STRAW+10)." Journal of Clinical Endocrinology & Metabolism. 2012;97(4):1159–1168.
- Stuenkel CA, et al. "Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline." Journal of Clinical Endocrinology & Metabolism. 2015;100(11):3975–4011.
- The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. "The 2022 Hormone Therapy Position Statement of The Menopause Society." Menopause. 2022;29(7):767–794.
- Baber RJ, Panay N, Fenton A; IMS Writing Group. "2016 IMS Recommendations on Women's Midlife Health and Menopause Hormone Therapy." Climacteric. 2016;19(2):109–150.
- Lobo RA, et al. "Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause." Atherosclerosis. 2016;254:282–290. (Timing hypothesis / cardiovascular window.)
- Thurston RC, et al. "Vasomotor symptoms and menopause: findings from the Study of Women's Health Across the Nation." Obstetrics and Gynecology Clinics of North America. 2011;38(3):489–501.
- U.S. Food and Drug Administration. Removal of Black Box Warning from Hormone Therapy Labeling. November 2025.
About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.


